Cargando…
Individualizing Systemic Therapies in First Line Treatment and beyond for Advanced Renal Cell Carcinoma
SIMPLE SUMMARY: In recent years, a number of new, effective treatments have become available for advanced renal (kidney) cancer. However, with more drugs available it has become more difficult to decide which drugs to choose for particular patients, and in which order to use them. In addition, the n...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764621/ https://www.ncbi.nlm.nih.gov/pubmed/33322163 http://dx.doi.org/10.3390/cancers12123750 |